Long-Term Proton Pump Inhibitor Use Linked to Nutrient Deficiencies and Mineral Imbalances
New research from the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) indicates that the prolonged use of proton pump inhibitors (PPIs)—such as omeprazole, pantoprazole, and esomeprazole—may disrupt the body’s ability to absorb essential nutrients. While these medications are standard treatments for acid reflux, gastritis, and ulcers, the study published in ACS Omega suggests that extended consumption can lead to mineral imbalances, potential bone health risks, and anemia.
Omeprazole has been in use for over 30 years, yet researchers warn that its trivialized use for mild symptoms—often without medical supervision—can lead to health complications when taken for months or years at a time.
The Impact of Acid Suppression on Nutrient Absorption
PPIs function by blocking the H+, K+, ATPase enzyme, which is responsible for the final stage of hydrochloric acid production in the stomach. While this suppression effectively eases gastric symptoms, stomach acid is a biological necessity for the proper absorption of minerals. When acid levels remain suppressed for extended periods, the body’s ability to process minerals like iron, calcium, zinc, magnesium, copper, and potassium is significantly compromised.
In the study, researchers tracked rats treated with omeprazole over 10, 30, and 60 days. The findings revealed that the drug caused minerals to build up in the stomach while creating concerning imbalances in the liver and spleen. Most notably, blood tests showed elevated calcium levels alongside reduced iron levels, which the researchers linked to an increased risk of osteoporosis and anemia.
Samantha Carter notes that the stakes of “trivialized” medication use are high. When patients treat mild heartburn as a chronic condition without professional oversight, they risk systemic nutrient deficiencies. The shift toward over-the-counter access requires a higher level of patient vigilance regarding the 14-day recommended limit to avoid these long-term physiological consequences.
Risks of Over-the-Counter Access
The regulatory landscape in Brazil shifted in November 2025, when the Brazilian Health Regulatory Agency (ANVISA) authorized the over-the-counter sale of 20mg omeprazole. While ANVISA maintains that this move promotes rational use by limiting packages to a 14-day supply, researchers are concerned that easy access encourages self-medication. Experts warn that patients may ignore the recommended two-week window, leading to continuous, unsupervised use.
What May Happen Next
Future clinical outcomes may center on the potency of newer PPIs. Researchers suggest that drugs like pantoprazole and esomeprazole might have even more intense side effects than omeprazole because they act more powerfully and for longer durations within the body. It is possible that medical providers will move toward more frequent screening for mineral deficiencies in patients who require long-term PPI therapy. Additionally, clinicians may increasingly evaluate the necessity of mineral supplementation for patients who cannot discontinue these medications, though such decisions will require individual medical supervision.
Frequently Asked Questions
Why is long-term omeprazole use linked to osteoporosis?
The study found a significant increase in calcium in the bloodstream of subjects, which researchers believe may indicate an imbalance caused by the removal of the mineral from the bones.
Do other PPIs carry the same risks as omeprazole?
Yes. Researchers emphasize that medications like pantoprazole and esomeprazole function similarly and may have an even stronger impact because they are more potent and act for longer periods.
What is the recommended duration for using omeprazole?
According to guidance cited by ANVISA, treatment should be limited to a maximum of 14 days to treat mild and temporary symptoms.
Are you monitoring the duration of your over-the-counter medication use with a healthcare professional?